Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW)

CUSIP: 68236X118

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / *W EXP 99/99/999
Total 13F shares
3,228,023
Share change
-160,901
Total reported value
$1,614,600
Price per share
$0.50
Number of holders
12
Value change
-$140,933
Number of buys
3
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 68236X118?
CUSIP 68236X118 identifies TOIIW - Oncology Institute, Inc. - *W EXP 99/99/999 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) as of Q2 2022

As of 30 Jun 2022, Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,228,023 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), HIGHBRIDGE CAPITAL MANAGEMENT LLC, Davidson Kempner Capital Management LP, Union Square Park Capital Management, LLC, WOLVERINE ASSET MANAGEMENT LLC, DIFESA CAPITAL MANAGEMENT, LP, Jefferies Group LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, Alpine Global Management, LLC, and TENOR CAPITAL MANAGEMENT Co., L.P.. This page lists 12 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.